MARS treatment in posthepatectomy liver failure

Liver International

Volumn 23, Issue SUPPL. 3, 2003, Pages 44-51

  van de Kerkhove, Maarten Paul ^a   de Jong, Koert P ^b   Rijken, Arjen M ^c   de Pont, Anne Cornélie J M ^a   van Gulik, Thomas M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

Author keywords

Hepatectomy; Liver; Liver failure; Liver resection; Liver support; MARS; Survival

Indexed keywords

TOXIN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY WATER; CLINICAL ARTICLE; EXPERIENCE; EXTRACTION; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER RESECTION; MALE; MEDICAL LITERATURE; NETHERLANDS; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN BINDING; SURGICAL MORTALITY; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0141925932     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1478-3231.23.s.3.2.x     Document Type: Article

References (27)

1. Lai E C, Fan S T, Lo C M, Chu K M, Liu C L, Wong J. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg 1995; 221: 291-8.
2. Dematteo R P, Fong Y, Blumgart L H. Surgical treatment of malignant liver tumors. Baillieres Best Pract Res Clin Gastroenterol 1999; 13: 557-74.
3. McCarter M D, Fong Y. Metastatic liver tumors. Semin Surg Oncol 2000; 19: 177-88.
4. Malafosse R, Penna C, Sa C A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12: 887-94.
5. Jarnagin W R, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis 1,803 consecutive cases over past decade. Ann Surg 2002; 236: 397-406.
6. Bozzetti F, Gennari L, Regalia E, et al. Morbidity and mortality after surgical resection of liver tumors: analysis 229 cases. Hepatogastroenterology 1992; 39: 237-41.
7. Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999; 188: 304-9.
8. Farges O, Malassagne B, Flejou J F, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999; 229: 210-5.
9. Dinant S, Van Vliet A K, Straatsburg I H, van Gulik T M. FLEXICOR study Academic Medical Center Amsterdam 2002 (unpublished work).
10. Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis 176 patients International MARS registry. Liver 2002; 22: 20-5.
11. Mitzner S R, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-86.
12. Schmidt L E, Sorensen V R, Svendsen L B, Hansen B A, Larsen F S. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 2001; 7: 1034-9.
13. Kellersmann R, Gassel H J, Buhler C, Thiede A, Timmermann W. Application of molecular adsorbent recirculating system in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. Liver 2002; 22: 56-8.
14. Conn H O, Lieberthal M M. The Hepatic Coma Syndromes and Lactulose. Baltimore: Williams & Wilkins, 1979.
15. Haber B, Naji L, Cressman D, Taub R. Coexpression of liver-specific and growth-induced genes in perinatal and regenerating liver: attainment and maintenance of the differentiated state during rapid proliferation. Hepatology 1995; 22: 906-14.
16. Rozga J. Hepatocyte proliferation in health and in liver failure. Med Sci Monit 2002; 8: RA32-8.
17. Mann D V, Lam W W, Hjelm N M, et al. Human liver regeneration hepatic energy economy is less efficient when organ is diseased. Hepatology 2001; 34: 557-65.
18. Kamath P S, Wiesner R H, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
19. Hamahata N, Nagino M, Nimura Y. APACHE III, unlike APACHE II, predicts posthepatectomy mortality in patients with biliary tract carcinoma: acute physiol chronic health evaluation. Crit Care Med 1998; 26: 1671-6.
20. Butt A K, Khan A A, Alam A, Shah S W, Shafqat F, Naqvi A B. Predicting hospital mortality in cirrhotic patients: comparison of Child-Pugh and acute physiology, age and chronic health evaluation (APACHE III) scoring systems. Am J Gastroenterol 1998; 93: 2469-75.
21. Mitzner S R, Stange J, Klammt S, Peszynski P, Schmidt R. Albumin dialysis using the molecular adsorbent recirculating system. Curr Opin Nephrol Hypertens 2001; 10: 777-83.
22. Hemming A W, Cattral M S, Reed A I, Van Der Werf W J, Greig P D, Howard R J. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001; 233: 652-9.
23. Okochi O, Kaneko T, Sugimoto H, Inoue S, Takeda S, Nakao A. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 2002; 103: 109-13.
24. Hwang E H, Taki J, Shuke N, et al. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999; 40: 1644-51.
25. Nonami T, Nakao A, Kurokawa T, et al. Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 1999; 46: 1669-72.
26. Zoedler T, Ebener C, Becker H, Roeher H D. Evaluation of liver function tests to predict operative risk in liver surgery. HPB Surg 1995; 9: 13-8.
27. Wilmer A, Nevens F, Evenepoel P, Hermans G, Fevery J. The molecular adsorbent recirculating system in patients with severe liver failure: clinical results at the K.U leuven. Liver 2002; 22: 52-5.